Nevirapin Sandoz Retard 400 mg, Retardtabletten
7680664830019
CH-66483
Tabletten
Associated product:
NEVIRAPINE Sandoz cpr ret 400 mg 30 pce
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
nevirapinum
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
povidonum K 25
|
- | Substance | HNIDK |
|
polyethyleni oxidum
|
- | Substance | HNIDK |
|
silica colloidalis
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 193.35
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2017
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 66483
- Drug name
- Nevirapin Sandoz Retard, Retardtabletten
- Galenic form
- RETT
- ATC Code
- J05AG01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 10/10/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- NEVIRAPINE Sandoz cpr ret 400 mg 30 pce
- Description (DE)
- NEVIRAPIN Sandoz Ret Tabl 400 mg 30 Stk
- Market launch
- 10/10/2017
- Narcotic (BTM)
- No